CIK 0001783036 · Non-accelerated filer<br>Emerging growth company
NewcelX Ltd.
Sign in to watch- Ticker
- NCEL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- other
- Phone
- 41-41-618-80-00
- Business address
- THE CIRCLE 6, 8058, ZURICH, Switzerland
- Former names
- NLS Pharmaceutics Ltd.
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- F-3 Offering F-3
- 425 Deal Prospectus/Communication re Business Combination
- 6-K Event Report of Foreign Issuer
- F-3 Offering F-3
- 6-K Event Report of Foreign Issuer
- 425 Deal Prospectus/Communication re Business Combination
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 425 Deal Prospectus/Communication re Business Combination
- 6-K Event Report of Foreign Issuer
- UPLOAD Other SEC-generated Letter
- D Other Notice of Sales of Unregistered Securities
- 425 Deal Prospectus/Communication re Business Combination
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 425 Deal Prospectus/Communication re Business Combination
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 425 Deal Prospectus/Communication re Business Combination
Page 8 of 21 · 419 filings